210 related articles for article (PubMed ID: 9794389)
21. The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes.
Klug CA; Gerety SJ; Shah PC; Chen YY; Rice NR; Rosenberg N; Singh H
Genes Dev; 1994 Mar; 8(6):678-87. PubMed ID: 7926758
[TBL] [Abstract][Full Text] [Related]
22. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line.
Rosa Santos SC; Dumon S; Mayeux P; Gisselbrecht S; Gouilleux F
Oncogene; 2000 Feb; 19(9):1164-72. PubMed ID: 10713704
[TBL] [Abstract][Full Text] [Related]
23. Arrested development: understanding v-abl.
Kerr LD
Bioessays; 1994 Jul; 16(7):453-5. PubMed ID: 7945272
[TBL] [Abstract][Full Text] [Related]
24. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
25. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
[TBL] [Abstract][Full Text] [Related]
26. The carboxyl terminus of v-Abl protein can augment SH2 domain function.
Warren D; Heilpern AJ; Berg K; Rosenberg N
J Virol; 2000 May; 74(10):4495-504. PubMed ID: 10775585
[TBL] [Abstract][Full Text] [Related]
27. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.
Chen YY; Rosenberg N
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6683-7. PubMed ID: 1379715
[TBL] [Abstract][Full Text] [Related]
28. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; GodÃnez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
29. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T
EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654
[TBL] [Abstract][Full Text] [Related]
30. Bcr/Abl activates transcription of the Bcl-X gene through STAT5.
Gesbert F; Griffin JD
Blood; 2000 Sep; 96(6):2269-76. PubMed ID: 10979976
[TBL] [Abstract][Full Text] [Related]
31. Pre-B-cells transformed by ts Abelson virus rearrange kappa and lambda [correction of gamma] genes in early G1.
Wang LC; Chen YY; Rosenberg N
Curr Top Microbiol Immunol; 1995; 194():355-61. PubMed ID: 7895509
[No Abstract] [Full Text] [Related]
32. v-Abl protein tyrosine kinase (PTK) mediated suppression of apoptosis is associated with the up-regulation of Bcl-XL.
Chen Q; Turner J; Watson AJ; Dive C
Oncogene; 1997 Oct; 15(18):2249-54. PubMed ID: 9393984
[TBL] [Abstract][Full Text] [Related]
33. The suppression of drug-induced apoptosis by activation of v-ABL protein tyrosine kinase.
Chapman RS; Whetton AD; Dive C
Cancer Res; 1994 Oct; 54(19):5131-7. PubMed ID: 7923130
[TBL] [Abstract][Full Text] [Related]
34. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor.
Guo D; Dunbar JD; Yang CH; Pfeffer LM; Donner DB
J Immunol; 1998 Mar; 160(6):2742-50. PubMed ID: 9510175
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells.
Foxwell BM; Beadling C; Guschin D; Kerr I; Cantrell D
Eur J Immunol; 1995 Nov; 25(11):3041-6. PubMed ID: 7489741
[TBL] [Abstract][Full Text] [Related]
36. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
Chai SK; Nichols GL; Rothman P
J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
[TBL] [Abstract][Full Text] [Related]
37. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5.
Lord JD; McIntosh BC; Greenberg PD; Nelson BH
J Immunol; 2000 Mar; 164(5):2533-41. PubMed ID: 10679091
[TBL] [Abstract][Full Text] [Related]
38. Cytokines and STAT signaling.
Schindler C; Strehlow I
Adv Pharmacol; 2000; 47():113-74. PubMed ID: 10582086
[No Abstract] [Full Text] [Related]
39. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells.
Murata T; Puri RK
Cell Immunol; 1997 Jan; 175(1):33-40. PubMed ID: 9015186
[TBL] [Abstract][Full Text] [Related]
40. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
Ferrag F; Chiarenza A; Goffin V; Kelly PA
Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
